![Han-Gu Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Förmögenhet: 5 M $ per 2026-09-30
Han-Gu Lee worked as the Co-Chief Executive Officer & Director at DAE HWA PHARM Co., Ltd., HLB Pharmaceutical Co., Ltd., and RedoxBio Co., Ltd. He started his job at HLB Pharmaceutical Co., Ltd. in 2016 and ended it in 2017.
Dr. Lee received his undergraduate and doctorate degrees from Sungkyunkwan University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-07-15 | 596 327 ( 3,2 % ) | 5 M $ | 2026-09-30 |
| Företag | Position | Slut |
|---|---|---|
RedoxBio Co., Ltd.
 RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells sodium hyaluronate | Verkställande Direktör | 2024-05-31 |
| HLB PHARMACEUTICAL CO., LTD. | Verkställande Direktör | 2017-05-31 |
| DAE HWA PHARMACEUTICAL CO., LTD. | Verkställande Direktör | 2015-03-20 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
| Privata företag | 4 |
|---|---|
DAE HWA PHARM Co., Ltd.
 DAE HWA PHARM Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sungkyunkwan University
 Sungkyunkwan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HLB Pharmaceutical Co., Ltd.
 HLB Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and related products based on biotechnology | Health Technology |
RedoxBio Co., Ltd.
RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells sodium hyaluronate | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
